Lilly Buys Sleep Disorders Drugmaker For Up To $7.8 Billion
The takeover fills a glaring hole in Eli Lilly's pipeline, says one analyst.

Source: Investor's Business Daily
The takeover fills a glaring hole in Eli Lilly's pipeline, says one analyst.
The takeover fills a glaring hole in Eli Lilly's pipeline, says one analyst.

Source: Investor's Business Daily